N-Acetyl Selank vs N-Acetyl Semax
A neutral, side-by-side comparison of two nootropic & cognitive peptides — their mechanisms, dosing ranges, administration routes, side effects, and research evidence. For research and educational purposes only.
N-Acetyl Selank
Acetylated variant of Selank with enhanced stability and bioavailability. The N-acetyl modification protects the peptide from rapid enzymatic degradation, extending its active half-life relative to standard Selank. Provides anxiolytic, nootropic, and immunomodulatory effects comparable to or exceeding standard Selank with potentially greater duration from each dose.
Full profileN-Acetyl Semax
N-Acetyl Semax is the acetylated form of Semax — an N-terminal acetyl group added to the standard Semax heptapeptide. The modification significantly improves resistance to aminopeptidases, extending the active half-life and producing a more sustained cognitive effect at lower doses. Considered by many researchers to be the preferred form of Semax for neurotrophin upregulation and focus enhancement.
Full profile| N-Acetyl Selank | N-Acetyl Semax | |
|---|---|---|
| Category | Nootropic & Cognitive | Nootropic & Cognitive |
| Also known as | Selank-A, N-Ac-Selank, acetylated selank, N-acetyl selank | NA-Semax, Acetyl-Semax, N-Ac-MEHFPGP |
| Evidence | Research-stage | Research-stage |
| Dosing range | 100mcg–500mcg mcg, 1–2x daily intranasal | 100mcg–600mcg mcg, Once daily (intranasal preferred) |
| Administration | Intranasal spray, Subcutaneous injection | Intranasal (preferred), Subcutaneous injection |
| Key side effects | Mild sedation (acute), Fatigue, Headache (rare), Nasal irritation (intranasal route) | Mild anxiety or over-stimulation at high doses, Nasal irritation (intranasal), Difficulty sleeping if dosed late in the day (more stimulating than standard Semax), Mild appetite suppression |
| Cited sources | 2 references | 2 references |
Key differences
- Administration: N-Acetyl Selank — Intranasal spray, Subcutaneous injection; N-Acetyl Semax — Intranasal (preferred), Subcutaneous injection.
- Frequency: N-Acetyl Selank is typically 1–2x daily intranasal; N-Acetyl Semax is Once daily (intranasal preferred).
How each works
N-Acetyl Selank
N-Acetyl Selank shares Selank's core mechanism — BDNF/NGF upregulation, enkephalinase inhibition, and GABA-A receptor complex modulation — with improved metabolic stability from the N-terminal acetyl group. The acetyl modification protects against aminopeptidase N and angiotensin-converting enzyme cleavage, extending the peptide's active residence time in neural tissue after intranasal administration.
N-Acetyl Semax
Acetylation of the N-terminus blocks aminopeptidase cleavage at the most vulnerable site on the Semax molecule, extending its effective duration in biological fluids. Studies comparing acetylated vs non-acetylated ACTH fragment analogs consistently show greater stability and sustained receptor engagement with acetylated forms. N-Acetyl Semax demonstrates the same core BDNF/NGF upregulating and neuroprotective profile as Semax with reported greater potency per mcg due to improved bioavailability.
This comparison aggregates public research and structured profile data for informational purposes only. It is not medical advice and does not recommend either compound for human use. Consult a qualified healthcare provider before considering any peptide.